glp 1 news GLP-1 Antagonists Increase Plan Drug Spend - What's Next GLP-1 Pipeline Update: August 2025

Healthcare providers are encouraged to educate patients about these risks and guide them toward safe, approved options

These symptoms often improve over time with continued use in most patients, and NPs can reduce discontinuation by starting at a low dose and titrating gradually

Studies show that adding lifestyle changes to GLP-1 treatment can reduce cardiovascular risk by up to 43 percent

Compounding the problem is the fact that insurance companies are reluctant to cover these anti-obesity medications, since theyre considered by many to be vanity drugs, even though overwhelming evidence suggests obesity is linked directly to multiple comorbidities

For some, the obsession over how much to eat or not eat can take over, and whats supposed to be a joyous and celebratory occasion is overshadowed by anxiety and shame

Fill out the form below, and discover the Serve You Rx difference.